XML 71 R52.htm IDEA: XBRL DOCUMENT v3.20.4
Note 17 - Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Notes Tables  
Schedule of Share-based Compensation Arrangement by Share-based Payment Award Fair Value Assumptions and Methodology [Table Text Block]
   

2020

   

2019

   

2018

 
                         

Dividend yield

    2.51 %     2.54 %     2.56 %

Expected volatility

    20.87 %     20.39 %     20.17 %

Risk free interest rate

    1.25 %     2.52 %     2.96 %

Expected life of SARs (years)

    7.1       7.2       7.0  
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   

Year Ended December 31, 2020

 

(in thousands)

 

Stock

Appreciation

Rights

   

Restricted

Stock

Awards

   

Restricted

Stock

Units

   

Performance

Stock

Units

   

Total

 
                                         

Expense

  $ 352     $ 1,346     $ 270     $ 1,294     $ 3,262  

Deferred tax benefit

    (74 )     (283 )     (57 )     (272 )     (686 )

Total net expense

  $ 278     $ 1,063     $ 213     $ 1,022     $ 2,576  
   

Year Ended December 31, 2019

 

(in thousands)

 

Stock

Appreciation

Rights

   

Restricted

Stock

Awards

   

Restricted

Stock

Units

   

Performance

Stock

Units

   

Total

 
                                         

Expense

  $ 345     $ 1,185     $ 329     $ 1,719     $ 3,578  

Deferred tax benefit

    (72 )     (249 )     (69 )     (361 )     (751 )

Total net expense

  $ 273     $ 936     $ 260     $ 1,358     $ 2,827  
   

Year Ended December 31, 2018

 

(in thousands)

 

Stock

Appreciation

Rights

   

Restricted

Stock

Awards

   

Restricted

Stock

Units

   

Performance

Stock

Units

   

Total

 
                                         

Expense

  $ 379     $ 1,100     $ 248     $ 2,300     $ 4,027  

Deferred tax benefit

    (80 )     (231 )     (52 )     (483 )     (846 )

Total net expense

  $ 299     $ 869     $ 196     $ 1,817     $ 3,181  
Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]

(in thousands)

Year Ended

 

Stock Appreciation Rights

   

Restricted Stock Awards

   

Restricted Stock Units

   

Performance Stock Units

   

Total

 
                                         

2021

  $ 304     $ 994     $ 1     $ 760     $ 2,059  

2022

    249       762             490       1,501  

2023

    174       546                   720  

2024

    68       292                   360  

2025

    9       28                   37  

Total estimated expense

  $ 804     $ 2,622     $ 1     $ 1,250     $ 4,677  
Share-based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]

(dollars in thousands, except per share and years)

 

SARs

   

 

Exercise

price

   

 

Weighted

average

exercise

price

   

 

Aggregate

intrinsic

value(1)

   

 

Weighted

average

fair

value

   

Weighted

average

remaining

contractual

life (in years)

 
                                                   

Outstanding, January 1, 2018

    704     $14.02 - 40.00     $ 19.51     $ 12,923     $ 3.47       5.1  

Granted

    100     35.90 - 39.32       37.75             6.07          

Exercised

    (73 )   14.02 - 19.37       15.32       1,654       3.43          

Forfeited

                                       

Outstanding, December 31, 2018

    731     $14.02 - 40.00     $ 22.42     $ 8,422     $ 3.83       5.2  
                                                   

Outstanding, January 1, 2019

    731     $14.02 - 40.00     $ 22.42     $ 8,422     $ 3.83       5.2  

Granted

    53     36.65 - 38.18       37.01       213       6.24          

Exercised

    (143 )   14.02 - 22.96       15.99       3,025       3.47          

Forfeited

                                       

Outstanding, December 31, 2019

    641     $14.02 - 40.00     $ 25.06     $ 10,250     $ 4.10       5.3  
                                                   

Outstanding, January 1, 2020

    641     $14.02 - 40.00     $ 25.06     $ 10,250     $ 4.10       5.3  

Granted

    48     37.30 - 37.30       37.30       154       5.80          

Exercised

    (96 )   14.02 - 25.76       16.33       2,401       2.88          

Forfeited

                                       

Outstanding, December 31, 2020

    593     $15.24 - 40.00     $ 27.47     $ 7,706     $ 4.44       5.1  
                                                   

Vested and exercisable

    412     $15.24 - 40.00     $ 23.44     $ 7,008     $ 3.83       4.0  

Unvested

    181     25.76 - 40.00       36.63       698       5.83       7.8  

Outstanding, December 31, 2020

    593     $15.24 - 40.00     $ 27.47     $ 7,706     $ 4.44       5.1  
                                                   

Vested in the current year

    68     $22.96 - 40.00     $ 32.11     $ 572     $ 5.10          
Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights, Award Expiration Period [Table Text Block]

(in thousands, except per share data)

                 

Expiration

 

SARs Outstanding

   

SARs Exercisable

   

Weighted Average Exercise Price

 

2021

    8       8       15.84  

2022

    42       42       15.26  

2023

    80       80       15.26  

2024

    73       73       19.37  

2025

    63       63       23.00  

2026

    79       63       25.84  

2027

    46       29       40.00  

2028

    100       42       37.75  

2029

    53       12       37.01  

2030

    49             37.30  
      593       412     $ 27.47  
Schedule of Nonvested Share Activity [Table Text Block]
           

Weighted

 
           

average cost

 

(in thousands, except per share data)

 

RSAs

   

at grant date

 
                 

Unvested at January 1, 2018

    119     $ 27.62  

Shares awarded

    40       35.89  

Restrictions lapsed and shares vested

    (44 )     23.62  

Shares forfeited

    (5 )     31.35  

Unvested at December 31, 2018

    110     $ 32.09  
                 

Unvested at January 1, 2019

    110     $ 32.09  

Shares awarded

    40       34.88  

Restrictions lapsed and shares vested

    (40 )     28.74  

Shares forfeited

    (2 )     35.36  

Unvested at December 31, 2019

    108     $ 34.31  
                 

Unvested at January 1, 2020

    108     $ 34.31  

Shares awarded

    36       39.30  

Restrictions lapsed and shares vested

    (41 )     32.38  

Shares forfeited

    (4 )     36.63  

Unvested at December 31, 2020

    99     $ 36.85  
Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]

Grant Year

 

Vesting Period in Years

   

Fair Value

   

Expected Shares to be Awarded

 

2018

  3       31.54       50,352  

2019

  3       32.03       36,127  

2020

  3       32.27       45,577  
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares to be Issued Upon Exercise and Remaining Shares Available for Future Issuance [Table Text Block]
   

Number of

           

Shares

 
   

shares to be

   

Weighted

   

available for

 
   

issued upon

   

average

   

future

 

Plan category (in thousands)

 

exercising/vesting

   

exercise price

   

issuance (a)

 
                         

Equity compensation plans approved by security holders:

                       

Stock Appreciation Rights

 

(b)

   

(b)

      432  

Restricted Stock Awards

    99       N/A    

(a)

 

Restricted Stock Units

    7       N/A    

(a)

 

Performance Stock Units

 

(c)

      N/A    

(a)

 

Total shares

    106               432